SYNTHETIC BIOLOGICS INC's ticker is SYN and the CUSIP is 87164U201. A total of 30 filers reported holding SYNTHETIC BIOLOGICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $20,000 | -41.2% | 74,300 | 0.0% | 0.00% | -100.0% |
Q3 2021 | $34,000 | -24.4% | 74,300 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $45,000 | -40.0% | 74,300 | -32.0% | 0.00% | 0.0% |
Q1 2021 | $75,000 | +78.6% | 109,300 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $42,000 | -19.2% | 109,300 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $52,000 | -7.1% | 109,300 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $56,000 | – | 109,300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Virtu Financial LLC | 306,479 | $87,000 | 0.01% |
1620 INVESTMENT ADVISORS, INC. | 15,000 | $4,000 | 0.00% |
Landmark Financial Advisors, LLC | 24,200 | $6,000 | 0.00% |
MSD Partners, L.P. | 116,430 | $33,000 | 0.00% |
IFP Advisors, Inc | 17,650 | $58,000 | 0.00% |
Jacobi Capital Management LLC | 18,500 | $5,000 | 0.00% |
Focused Wealth Management, Inc | 500 | $0 | 0.00% |
JANE STREET GROUP, LLC | 281,700 | $80,000 | 0.00% |
UBS Group AG | 79,851 | $23,000 | 0.00% |
BNP PARIBAS FINANCIAL MARKETS | 1 | $0 | 0.00% |